Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia [Phase 3]
Open-label Phase 3 study of KarXT in schizophrenia was terminated; results were posted on 2024-06-12.
-
FDA approval · 2024-06-07FDA Approved: FLUPHENAZINE HYDROCHORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings' generic fluphenazine hydrochloride via Original Application (ANDA), a generic antipsychotic used to tre…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: A Neurofeedback Intervention to Improve Working Memory in Schizophrenia [NA]
A completed UC San Diego trial evaluated neurofeedback as a method to improve working memory in individuals with schizophrenia.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders. [NA]
A clinical trial sponsored by University Hospital, Grenoble, aims to estimate the prevalence of inherited disorders of sulfur amino acid met…
-
FDA approval · 2024-05-29FDA Approved: OLANZAPINE — Supplemental Application (Sandoz Inc)
FDA approved Sandoz Inc.'s supplemental application for olanzapine (ANDA201588). This action updates the approval for the generic product, p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: The Danish Region Midt Schizophrenia Cohort
This clinical trial update indicates ongoing recruitment for the Danish Region Midt Schizophrenia Cohort, sponsored by the University of Aar…
-
FDA approval · 2024-05-28FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for aripiprazole submitted by Alembic Pharmaceuticals Inc., authorizing a modification to the pr…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia [Phase 2, Phase 3]
The document reports the termination of a Phase 2/3 clinical trial evaluating AVP-786 for the treatment of negative symptoms in schizophreni…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults [Phase 2, Phase 3]
A Phase 2/Phase 3 study evaluating NaBen as an add-on treatment for schizophrenia in adults has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders [NA]
A clinical trial is evaluating whether combining MCT with CR improves recovery in patients with psychotic spectrum disorders; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Brain Stimulation, Clinical Symptoms and Cognition [NA]
A brain stimulation clinical trial for schizophrenia conducted by UC Davis has completed.
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia [NA]
Clinical trial in Pakistan evaluating adding Individual Placement and Support and/or Cognitive Remediation Therapy to treatment as usual for…
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care [NA]
This entry reports on a clinical trial evaluating metacognitive skills training for individuals in forensic psychiatric care, with recruitme…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Brain Stimulation and Cognitive Training - Efficacy [NA]
This clinical trial update reports efficacy results for a brain stimulation and cognitive training intervention in schizophrenia, schizoaffe…
-
CLINICAL_TRIALS withdrawal · 2024-05-09Clinical Trial Update: Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® [Phase 2, Phase 3]
An adaptive Phase II/III trial of NaBen for schizophrenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders [NA]
The completed clinical trial evaluated the efficacy of prebiotic and probiotic dietary modulation in schizophrenia, sponsored by Universidad…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Goals in Focus: CBT for Motivational Negative Symptoms of Psychosis [NA]
An ongoing clinical trial at the University of Hamburg-Eppendorf is evaluating cognitive-behavioral therapy for motivational negative sympto…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With Schizophrenia [NA]
A clinical trial evaluating whether switching to high- or low-nicotine strength electronic cigarettes affects cigarette consumption in peopl…
-
FDA approval · 2024-05-07FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Rexulti (brexpiprazole) by Otsuka America Pharmaceutical, Inc.
-
FDA approval · 2024-05-06FDA Approved: PERPHENAZINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves an original application for a generic version of perphenazine by Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia [Phase 4]
Phase 4 trial investigating biomarkers for conversion risk and treatment response in early-stage schizophrenia has completed with results po…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Investigating the Neural Correlates of Cognitive Function in Psychosis Patients and Non-Psychiatric Controls With Cannabis Use [NA]
This clinical trial investigates neural correlates of cognitive function in individuals with psychotic disorders who use cannabis, compared …
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia [NA]
This completed clinical trial investigated the role of inflammation in reward circuits and motivational/negative symptoms in people with sch…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Using mHealth to Optimize Pharmacotherapy Regimens [NA]
This is a completed clinical trial update about using mobile health (mHealth) tools to optimize pharmacotherapy regimens for schizophrenia a…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Anti-Inflammatory Challenge in Schizophrenia [Phase 4]
Phase 4 clinical trial update for an anti-inflammatory approach in schizophrenia sponsored by Emory University. The study (NCT05823532) is c…